Influenza A defective interfering particles as broad-spectrum antivirals

Authors

• Sascha Young Kupke, Max Planck Institute for Dynamics of Complex Technical Systems, Germany
• L Pelz, Max Planck Institute for Dynamics of Complex Technical Systems, Bioprocess Engineering, GER
• D Ruediger, Max Planck Institute for Dynamics of Complex Technical Systems, Bioprocess Engineering, GER
• T Dogra, Max Planck Institute for Dynamics of Complex Technical Systems, Bioprocess Engineering, GER
• J Boehme, Helmholtz Centre for Infection Research, Immune Regulation, Braunschweig, GER
• O Kershaw, Freie Universitaet Berlin, Department of Veterinary Pathology, GER
• D Bruder, Helmholtz Centre for Infection Research, Immune Regulation, Braunschweig, GER
• U Reichl, Bioprocess Engineering, Magdeburg, GER

Conference Dates

May 19 - 24, 2024

Abstract

Please click Additional Files below to see the full abstract.

Recommended Citation

Sascha Young Kupke, L Pelz, D Ruediger, T Dogra, J Boehme, O Kershaw, D Bruder, and U Reichl, "Influenza A defective interfering particles as broad-spectrum antivirals" in "Vaccine Technology IX", Linda Lua, The University of Queensland, Australia; Charles Lutsch, Sanofi-Vaccines, France; Francesc Gòdia, Universitat Autònoma de Barcelona (UAB), Spain; Tara Tagmyer, CMC Leader, USA Eds, ECI Symposium Series, (2024). https://dc.engconfintl.org/vaccine_ix/63